Clincosm LogoSign in Get a demo

metastatic renal cell carcinoma

Showing 26 - 50 of 152
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Real-world Clinical Patterns Of Care And Outcomes Among AfME

Recruiting
  • Metastatic Renal Cell Carcinoma
  • Algers, Algeria
  • +5 more
Aug 16, 2022

Metastatic Renal Cell Carcinoma, Good or Only One Adverse Prognostic Factor Intermediate Risk Per IMDC Score Trial in France

Not yet recruiting
  • Metastatic Renal Cell Carcinoma
  • Good or Only One Adverse Prognostic Factor Intermediate Risk Per IMDC Score
  • Combination PD-1/PD-L1 ICI + VEGFR-TKI
  • Treatment pause
  • Bayonne, France
  • +24 more
Aug 10, 2022

Cardiovascular Disorder, Chronic Kidney Disease, Metastatic Renal Cell Carcinoma Trial in United States (Best Practice, Blood

Recruiting
  • Cardiovascular Disorder
  • +8 more
  • Best Practice
  • +4 more
  • Creve Coeur, Missouri
  • +24 more
Aug 10, 2022

Metastatic Renal Cell Carcinoma Trial in Lebanon, Burlington (Sunitinib, Temsirolimus)

Active, not recruiting
  • Metastatic Renal Cell Carcinoma
  • Lebanon, New Hampshire
  • +1 more
Aug 9, 2022

Kidney Cancer, Renal Cell Carcinoma, Unresectable Renal Cell Carcinoma Trial in United States (Talazoparib, Axitinib)

Recruiting
  • Kidney Cancer
  • +3 more
  • Basking Ridge, New Jersey
  • +6 more
Aug 8, 2022

Metastatic Renal Cell Carcinoma, Radiotherapy Trial in France (Steretactic radiotherapy, Pursuit of ongoing systemic treatment)

Recruiting
  • Metastatic Renal Cell Carcinoma
  • Radiotherapy
  • Steretactic radiotherapy
  • Pursuit of ongoing systemic treatment
  • Albi, France
  • +17 more
Aug 9, 2022

Metastatic Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8, Stage IV Renal Cell Cancer AJCC v8 Trial in United States

Recruiting
  • Metastatic Renal Cell Carcinoma
  • +3 more
  • Avelumab
  • +7 more
  • Danville, Illinois
  • +4 more
Jul 29, 2022

Malignant Tumors of Urinary Tract, Oligometastatic Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma Trial in Houston

Recruiting
  • Malignant Neoplasms of Urinary Tract
  • +3 more
  • Stereotactic Body Radiation Therapy
  • Houston, Texas
    M D Anderson Cancer Center
Jul 14, 2022

Metastatic Renal Cell Carcinoma Trial in Boston (HD IL2)

Completed
Has Results
  • Metastatic Renal Cell Carcinoma
  • HD IL2
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Jun 20, 2022

Diarrhea, Metastatic Renal Cell Carcinoma, Stage IV Renal Cell Cancer Trial in Duarte (other, dietary supplement, drug)

Active, not recruiting
  • Diarrhea
  • +2 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Jun 7, 2022

Advanced Breast Carcinoma, Advanced Endometrial Carcinoma, Advanced Fallopian Tube Carcinoma Trial in Houston (biological, drug,

Recruiting
  • Advanced Breast Carcinoma
  • +73 more
  • Atezolizumab
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
May 5, 2022

Metastatic Renal Cell Carcinoma Trial in France (PRISM care program)

Recruiting
  • Metastatic Renal Cell Carcinoma
  • PRISM care program
  • Angers, France
  • +11 more
Apr 22, 2022

Metastatic Castration-resistant Prostate Cancer (mCRPC), Metastatic Urothelial Carcinoma, Metastatic Renal Cell Carcinoma Trial

Completed
  • Metastatic Castration-resistant Prostate Cancer (mCRPC)
  • +2 more
  • Isovue-M 200
  • Durham, North Carolina
    Duke University Medical Center
Apr 1, 2022

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8

Recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +129 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Apr 8, 2022

Advanced Differentiated Thyroid Gland Carcinoma, Advanced Head and Neck Carcinoma, Advanced Hepatocellular Carcinoma Trial in

Recruiting
  • Advanced Differentiated Thyroid Gland Carcinoma
  • +102 more
  • Cabozantinib S-malate
  • Nivolumab
  • Chicago, Illinois
  • +2 more
Apr 5, 2022

Metastatic Renal Cell Carcinoma, Metastatic Clear-cell Renal Cancer, Recurrent Renal Cell Carcinoma Trial in Iowa City,

Completed
  • Metastatic Renal Cell Carcinoma
  • +4 more
  • HyperAcute®-Renal (HAR) Immunotherapy
  • Iowa City, Iowa
  • +2 more
Apr 4, 2022

Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma Trial in Worldwide (bempegaldesleukin, sunitinib, nivolumab)

Active, not recruiting
  • Renal Cell Carcinoma
  • Metastatic Renal Cell Carcinoma
  • bempegaldesleukin
  • +3 more
  • Anchorage, Alaska
  • +108 more
Mar 31, 2022

Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma Trial in Palo Alto (Doppler ultrasound, Long Ensemble Angular-coherence

Recruiting
  • Renal Cell Carcinoma
  • Metastatic Renal Cell Carcinoma
  • Doppler ultrasound
  • +2 more
  • Palo Alto, California
    Stanford
Mar 22, 2022

Metastatic Renal Cell Carcinoma Trial in Australia, Canada (Ipilimumab/ Nivolumab, SBRT + Ipilimumab/Nivolumab)

Recruiting
  • Metastatic Renal Cell Carcinoma
  • Ipilimumab/ Nivolumab
  • SBRT + Ipilimumab/Nivolumab
  • Melbourne, Australia
  • +7 more
Mar 30, 2022

Metastatic Renal Cell Carcinoma, Stage IV Renal Cell Cancer AJCC v8 Trial in Duarte (Behavioral Intervention, Quality-of-Life

Recruiting
  • Metastatic Renal Cell Carcinoma
  • Stage IV Renal Cell Cancer AJCC v8
  • Behavioral Intervention
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Mar 9, 2022

Metastatic Renal Cell Carcinoma, Clear-cell Metastatic Renal Cell Carcinoma Trial in Philadelphia (Cabozantinib)

Recruiting
  • Metastatic Renal Cell Carcinoma
  • Clear-cell Metastatic Renal Cell Carcinoma
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Mar 2, 2022

Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma, Kidney Cancer Trial in Baltimore (Olaparib)

Recruiting
  • Renal Cell Carcinoma
  • +4 more
  • Baltimore, Maryland
    Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Mar 14, 2022

Advanced Solid Tumors, Metastatic Renal Cell Carcinoma Trial in United States (Part 1: M8891)

Terminated
Has Results
  • Advanced Solid Tumors
  • Metastatic Renal Cell Carcinoma
  • Part 1: M8891
  • New Haven, Connecticut
  • +6 more
Dec 21, 2021

Metastatic Renal Cell Carcinoma Trial in Worldwide (Ipilimumab plus nivolumab, Standard Therapy)

Recruiting
  • Metastatic Renal Cell Carcinoma
  • Ipilimumab plus nivolumab
  • Standard Therapy
  • Gent, Belgium
  • +40 more
Feb 7, 2022

Urine Omics Predicting IO Therapy Responses in mRCC Patients

Recruiting
  • Metastatic Renal Cell Carcinoma
  • No intervention required
  • Taipei, Taiwan
    National Taiwan University Hospital
Jan 18, 2022